Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
LCNB Corp
LCNB
$286M
| $561K | ﹤0.01% |
34,300
-13,400
| -28% | -$216K |
|
|
DLA
2702
DELISTED
Delta Apparel Inc.
DLA
| $559K | ﹤0.01% |
39,800
+19,400
| +95% | +$310K |
|
|
REXI
2703
DELISTED
RESOURCE AMERICA INC CL-A
REXI
| $559K | ﹤0.01% |
91,200
+32,000
| +54% | +$196K |
|
2704
Ezcorp Inc
EZPW
$1.79B
| $558K | ﹤0.01% |
111,727
-198,649
| -64% | -$1.17M |
|
|
PRAH
2705
DELISTED
PRA Health Sciences, Inc.
PRAH
| $552K | ﹤0.01% |
12,200
-37,700
| -76% | -$1.58M |
|
|
CTO
2706
CTO Realty Growth
CTO
$820M
| $548K | ﹤0.01% |
38,314
-15,841
| -29% | -$228K |
|
2707
Smith Micro Software
SMSI
$13.9M
| $547K | ﹤0.01% |
4,693
+258
| +6% | +$31.6K |
|
|
COB
2708
DELISTED
CommunityOne Bancorp
COB
| $547K | ﹤0.01% |
40,600
+19,300
| +91% | +$256K |
|
|
VIA
2709
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $545K | ﹤0.01% |
+10,520
| New | +$469K |
|
2710
Taoping
TAOP
$6.14M
| $544K | ﹤0.01% |
180
-10
| -5% | -$19.8K |
|
2711
Limoneira
LMNR
$241M
| $539K | ﹤0.01% |
36,100
+17,400
| +93% | +$281K |
|
|
HAYN
2712
DELISTED
Haynes International, Inc.
HAYN
| $539K | ﹤0.01% |
14,700
-15,300
| -51% | -$594K |
|
2713
Lincoln Educational Services
LINC
$1.33B
| $536K | ﹤0.01% |
269,200
-14,500
| -5% | -$23K |
|
|
AMBR
2714
DELISTED
Amber Road Inc
AMBR
| $535K | ﹤0.01% |
105,200
+52,292
| +99% | +$237K |
|
2715
FuelCell Energy
FCEL
$1.89B
| $533K | ﹤0.01% |
+299
| New | +$963K |
|
2716
V2X
VVX
$2.72B
| $530K | ﹤0.01% |
+25,364
| New | +$591K |
|
|
ACW
2717
DELISTED
Accuride Corp
ACW
| $530K | ﹤0.01% |
319,078
+111,878
| +54% | +$278K |
|
|
SYUT
2718
DELISTED
Synutra International, Inc.
SYUT
| $528K | ﹤0.01% |
112,100
-56,900
| -34% | -$292K |
|
|
SWSH
2719
DELISTED
SWISHER HYGIENE INC COM STK NEW (DE)
SWSH
| $524K | ﹤0.01% |
546,050
+64,600
| +13% | +$67.8K |
|
|
VYNT
2720
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $521K | ﹤0.01% |
1,053
+506
| +93% | +$366K |
|
|
EGLT
2721
DELISTED
Egalet Corporation
EGLT
| $521K | ﹤0.01% |
47,300
+15,500
| +49% | +$154K |
|
|
IMBI
2722
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $517K | ﹤0.01% |
29,056
-4,190
| -13% | -$99.4K |
|
|
IMGN
2723
DELISTED
Immunogen Inc
IMGN
| $516K | ﹤0.01% |
38,040
-355,400
| -90% | -$4.37M |
|
2724
Insight Enterprises
NSIT
$3.86B
| $515K | ﹤0.01% |
20,500
-63,473
| -76% | -$1.67M |
|
|
SMT
2725
DELISTED
SMART TECHNOLOGIES INC COM NEW
SMT
| $514K | ﹤0.01% |
176,892
+8,722
| +5% | +$35.4K |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.